About Syntax
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
Undisclosed
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
syntax-bio.com
Domain Registered Date
Jan 2, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $14,400,000 · Venture Round
fundraisingfox.com
- Milestone
Website domain registered
syntax-bio.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Syntax.
Funding History
Venture Round
· Jun 22, 2026
$14,400,000 fundraisingfox.com
Founders & Leadership
Brad Merrill
Co-Founder, Head of Innovation
Work email & phone locked
Unlock →
Doug Doerfler
Founder, CEO, Board Advisor
Work email & phone locked
Unlock →
Niko Balanis
Co-Founder, Chief Technology Officer
Work email & phone locked
Unlock →
Ryan Clarke
Co-Founder, Chief Scientific Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026